RBS

Provectus Biopharmaceuticals Announces Acceptance of Small Molecule Cancer Immunotherapy PV-10® Stage III Melanoma Abstract at Melanoma Bridge 2022

Retrieved on: 
Thursday, November 10, 2022
GLOBE, Dermatology, Forward-looking statement, National, U.S. Securities and Exchange Commission, World Health Organization, INN, Merck, NIH, WHO, Hematology, Ophthalmology, Legislation, Wound healing, SEC, HX, Safety, Infection, International, ClinicalTrials.gov, Company, OTCQB, RBS, Disease, Pembrolizumab, Merck Sharp & Dohme Federal Credit Union, Melanoma, World, Security (finance), Merck & Co., API, Cell death, Pharmaceutical industry, U.S.A

Importantly, Provectus pharmaceutical-grade RBS displays different therapeutic effects at different concentrations and can be formulated for delivery by different routes of administration.

Key Points: 
  • Importantly, Provectus pharmaceutical-grade RBS displays different therapeutic effects at different concentrations and can be formulated for delivery by different routes of administration.
  • The International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) selected rose bengal sodium for the nonproprietary name of the Companys API.
  • First, direct contact may lead to cell death or repair depending on the disease being treated and the concentration of Provectus RBS utilized in the treatment.
  • Due to the risks, uncertainties, and assumptions inherent in forward-looking statements, readers should not place undue reliance on these forward-looking statements.

Provectus Biopharmaceuticals Announces World Health Organization Selection of “Rose Bengal Sodium” as International Nonproprietary Name for Active Pharmaceutical Ingredient

Retrieved on: 
Wednesday, November 2, 2022
API, CMC, Pharmacovigilance, Security (finance), Dermatology, World Health Organization, International, Infection, U.S. Securities and Exchange Commission, Epson HX-20, Legislation, SEC, Wound healing, GLOBE, Documentation, P.O, NIH, Ophthalmology, WHO, Immunotherapy, Hematology, World, Volume, Safety, No, HX, National, Company, Review, IL, The International Pharmacopoeia, Communication, Patient, Forward-looking statement, RBS, Drug discovery, OTCQB, Fine chemical, Pharmaceutical industry

KNOXVILLE, TN, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) has selected rose bengal sodium (RBS) for the nonproprietary name of the Companys active pharmaceutical ingredient (API).

Key Points: 
  • KNOXVILLE, TN, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the International Nonproprietary Names (INN) Expert Committee of the World Health Organization (WHO) has selected rose bengal sodium (RBS) for the nonproprietary name of the Companys active pharmaceutical ingredient (API).
  • Dominic Rodrigues, Vice Chair of Provectus Board of Directors, said The World Health Organizations International Nonproprietary Names system has facilitated the name of rose bengal sodium for the active pharmaceutical ingredient that is the foundation of our clinical development and drug discovery programs comprising a number of different disease areas.
  • We believe that finalizing this name is an important step towards enabling drug regulatory agencies to ensure strong pharmacovigilance of rose bengal sodium in medicines.
  • Mr. Rodrigues added, Provectus recognizes the significant body of international research into non-pharmaceutical grades of rose bengal for the treatment of other diseases.

Flashpoint Expands C-Suite Team With New Chief Intelligence Officer and Chief Product Officer

Retrieved on: 
Wednesday, November 2, 2022
Banking, Technology, Professional Services, Transportation, Travel, Utilities, Oil, Gas, Security, Energy, Software, Retail, Networks, Internet, Insurance, Supply Chain Management, Finance, Consulting, United States Navy, Growth, Corporation, Corporate security, Culture, Public security, Leadership, Empathy, Automation, CPO, CTI, Organization, Intelligence, Risk, OSINT, High-functioning autism, CIO, National security, ICEX: US Navy Mission in Arctic, Forbes Global 2000, Fraud, Vulnerability management, Public sector, Booz Allen Hamilton, Time, Multimedia, Security, Symantec, PNC, Solution, RBS, Risk management, Flashpoint

On the heels of a year of rapid growth that includes two acquisitions, Flashpoint, the globally trusted leader in actionable risk intelligence, today introduced Tom Hofmann as Chief Intelligence Officer (CIO) and Patrick Gardner as Chief Product Officer (CPO).

Key Points: 
  • On the heels of a year of rapid growth that includes two acquisitions, Flashpoint, the globally trusted leader in actionable risk intelligence, today introduced Tom Hofmann as Chief Intelligence Officer (CIO) and Patrick Gardner as Chief Product Officer (CPO).
  • Prior to joining Flashpoint, Hofmann led cyber threat intelligence (CTI) operations at PNC, managed CTI collections at Booz Allen, and served as an Information Warfare Officer for the US Navy.
  • Tom is one of the foremost intelligence and security experts in the world, says Flashpoint CEO Josh Lefkowitz.
  • In January, Flashpoint acquired vulnerability intelligence leader Risk Based Security (RBS); and in August, Flashpoint acquired open source intelligence leader Echosec Systems.

Rutgers Part-Time MBA concentration in global business paid dividends for recent graduate

Retrieved on: 
Tuesday, November 1, 2022
News, Growth, Imran, MBA, Leadership, Starbucks, Program, Rutgers Business School – Newark and New Brunswick, Organization, Master of Business Communication, Rutgers University, Work, Cranford, Student, Department, Military, SME, Management, Business, No, Xavier University MBA Program, Gaur, Compliance, Learning, Assistant, Madison Avenue, Multimedia, Financial management, Solution, RBS, Parent, Sony Music, Tutoring

NEWARK, N.J., Nov. 1, 2022 /PRNewswire/ -- Even before Andrew Plotkin completed his Rutgers MBA, the degree had helped him advance at Sony Music Entertainment.

Key Points: 
  • NEWARK, N.J., Nov. 1, 2022 /PRNewswire/ -- Even before Andrew Plotkin completed his Rutgers MBA , the degree had helped him advance at Sony Music Entertainment.
  • Plotkin said his MBA studies began paying off with his first courseat Rutgers Business School in May 2019.
  • News, Rutgers Business School's Part-Time MBA program is an excellent option for professionals wishing to advance their careers.
  • Gaur said the global business concentration equips students with these and other leadership skills they need to emerge as the winning leaders of global companies in the coming decades.

Ashman Bank partners with nCino to bolster its tech platform, after being awarded first UK banking licence of the year

Retrieved on: 
Thursday, October 27, 2022
HSBC, Ashman, Capital One, Financial services, Prudential regulation, NASDAQ, Financial Conduct Authority, NCino, Australian Prudential Regulation Authority, Automation, SME, Technology, Industry, Compliance, Bank, GLOBE, Name, Edmund Street, EMEA, Efficiency, RBS, Partnership, Real estate, Barclays, Aldermore

Ashman Bank, which was awarded the UKs first new banking licence in 2022, has selected nCinos Bank Operating System as its foundational technology for its life cycle property finance solution, from refurbishment right through to development and investment.

Key Points: 
  • Ashman Bank, which was awarded the UKs first new banking licence in 2022, has selected nCinos Bank Operating System as its foundational technology for its life cycle property finance solution, from refurbishment right through to development and investment.
  • Partnering with nCino takes us one step closer to being able to transform the banking experience for property SMEs, Caroline Luxmore, Chief Commercial Officer at Ashman Bank added.
  • Ashman Bank is an ambitious new entrant that will provide real estate lending for conscientious businesses in the UK.
  • The nCino Bank Operating System empowers financial institutions with scalable technology to help them achieve revenue growth, greater efficiency, cost savings and regulatory compliance.

Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation

Retrieved on: 
Tuesday, October 25, 2022
Psoriasis, Skin, U.S. Securities and Exchange Commission, Dermatology, RBS, IL, SEC, Growth, Ophthalmology, Pulsus Group, Laboratory, CXCL1, Keratinocyte, NIH, Cell, Security (finance), Secondary research, Senior, Infection, Trial of the century, Company, Drug discovery, Doctor of Philosophy, MD, National, Legislation, Convoy HX 156, Rockefeller University, Immunotherapy, Safety, HX, GLOBE, P.O, Interferon, Forward-looking statement, Hematology, Center, OTCQB, Kruger, IL-19, Pharmaceutical industry

They also hope to determine PH-10s interaction with and uptake by blood leukocytes, because these cells mediate inflammatory skin diseases and control or protect against some types of skin cancers.

Key Points: 
  • They also hope to determine PH-10s interaction with and uptake by blood leukocytes, because these cells mediate inflammatory skin diseases and control or protect against some types of skin cancers.
  • Provectus Biopharmaceuticals, Inc. (Provectus or the Company) is a clinical-stage biotechnology company developing immunotherapy medicines for different disease areas based on a class of small molecules called halogenated xanthenes (HXs).
  • Due to the risks, uncertainties, and assumptions inherent in forward-looking statements, readers should not place undue reliance on these forward-looking statements.
  • Risks, uncertainties, and assumptions include those discussed in the Companys filings with the Securities and Exchange Commission (SEC), including those described in Item 1A of:

[0] Presents the ØRB System: The first interoperable Metaverse device for 360 spatial content streaming

Retrieved on: 
Monday, October 24, 2022
Non-fungible token, Spatial contextual awareness, NFT, Music, Multimedia, ETH, RB, RBS, IP, EST, VR, GLB, Video game console, Metaverse

NEW YORK, Oct. 24, 2022 /PRNewswire/ - [0] ( 0.xyz ), Metaverse Innovation Lab & IP company with a mandate to "Build a Better Metaverse," will be launching their first Metaverse product, the "RB" System (pronounced "orb"), an interoperable, content streaming device in which users can immerse themselves in 360, spatialized content.

Key Points: 
  • NEW YORK, Oct. 24, 2022 /PRNewswire/ - [0] ( 0.xyz ), Metaverse Innovation Lab & IP company with a mandate to "Build a Better Metaverse," will be launching their first Metaverse product, the "RB" System (pronounced "orb"), an interoperable, content streaming device in which users can immerse themselves in 360, spatialized content.
  • The first 2,500 RBs will receive an airdropped 360 immersive experience NFT created by Metaverse artist and [0] Co-Founder Krista Kim.
  • "RBsystem" is the first-ever all-in-one interoperable content streaming system for the Open Metaverse.
  • RB Systemlets owners stream 360 experiential NFT content of art, music, and VR streaming libraries.

Fimatix partners with regtech firm Corlytics in next stage of enhanced private sector offering

Retrieved on: 
Thursday, October 20, 2022
Nova, Insurance, Risk, RBS, Mobility as a service, ESG, Partnership, The Big Exchange, Technology, UK, Acquisition, IDEAS Group, Corlytics, Industry, AI, Home Office, Prodigy, Natural language processing, HSBC, Government, Heart, Map, Home, Private, Solution, Compliance, Audit, Industrial design

LONDON, Oct. 20, 2022 /PRNewswire/ --Through this partnership, the two firms will integrate each other's services into their own offerings, creating a combined suite of products and solutions capable of augmenting regulation and change management systems across the financial services and insurance sectors.

Key Points: 
  • Two of the leading tech innovators, digital consultancy Fimatix and regulatory risk intelligence firm Corlytics, have agreed to formalise their partnership.
  • Its partnership with Corlytics follows Fimatix's recent expansion of its private sector practice, including the appointment of Sanjeev Dhiman as Chief Business Officer for Private Sector Business and the acquisition of Idea Group in May.
  • The partnership strengthens Fimatix's wider digital transformation offering, which enables organisations to expertly accelerate their digital development.
  • With the team at Fimatix we've become well-acquainted with Corlytics' innovation, expertise, and state of the art regtech products.

SMBC Continues Growth With New Human Resources, Strategy & Transformation Appointments

Retrieved on: 
Wednesday, October 19, 2022
Professional Services, Other Professional Services, Insurance, Human Resources, Finance, Banking, Personal Finance, HR, CFO, Sumitomo Mitsui Banking Corporation, Corporation, University, Economics, CHRO, NYSE, MBA, Farmer's and Manufacturer's Bank, Senior, Corporate services, Corporate real estate, Head, Maintenance, Transformation, Procurement, SMFG, Fordham, Leadership, RBS, Strategy, Turnaround ADR, Growth, Workforce, Providence College, Goal, Market, General Electric, Royal Bank, Robin, Business, Royal Bank of Scotland, Virtual CFO, Group, Financial management, JPMorgan Chase, Information, Management, Financial services, Science, SMBC

SMBC, a member of SMBC Group, announced today the appointment of Robin Milberg as Chief Human Resources Officer (CHRO) and Paul Sweeney as Head of Strategy & Transformation.

Key Points: 
  • SMBC, a member of SMBC Group, announced today the appointment of Robin Milberg as Chief Human Resources Officer (CHRO) and Paul Sweeney as Head of Strategy & Transformation.
  • This hands-on, relationship-based approach differentiates us, but is also predicated on a skilled and engaged workforce following and building upon a common strategy.
  • Pauls approach to strategy and transformation epitomizes a comprehensive and effective approach focused on execution, added Freer.
  • In this role, he led this groups transformation through the identification and delivery of functional enhancements that support SMBCs business strategy.

Outlook on the Automotive Energy Recovery System Global Market to 2030 - by Vehicle Type, Product Type and Region - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 6, 2022
Vehicle Technology, Automotive, General Automotive, EV, Electric Vehicles, Oil, Gas, Energy, Hyundai Motor Group, Adoption, CAGR, Porter's five forces analysis, Industry, RBS, Gas, Torque, Technology, Renewable energy, Risk management

The "Automotive Energy Recovery System Market By Vehicle Type, By Product Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Automotive Energy Recovery System Market By Vehicle Type, By Product Type: Global Opportunity Analysis and Industry Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.
  • The automotive energy recovery system is used to recover the moving vehicle's kinetic energy under braking and convert it into electrical energy stored in a battery, supercapacitor, or mechanical energy in a flywheel.
  • Automobile manufacturers are currently focused on producing advanced automotive energy recovery systems with a high-efficiency rate and low cost.
  • The current automotive energy recovery system industry is quantitatively analyzed from 2021 to 2030 to benchmark financial competency.